N,N diethyl-N'phenylpiperazine alpha 7 and alpha 9 nicotinic acetylcholine receptor agonists and antagonists
Provided are embodiments of para-substituted 1,1-dialkyl-4-phenylpiperazin-1-ium iodides advantageous for modulating inflammation that have been synthesized and their electrophysiology activities for α9, α9α10, and α7 nAChRs compared. The para position contained alkyl or aryl amides, or heterocyclic isosteres for the amide, and the alkyl groups were varied at the ammonium piperazine nitrogen to see if compensatory changes in size at this position of the molecule impacted function. The compounds were characterized with two-electrode voltage-clamp measurements on Xenopus oocytes expressing nAChRs. General, the compounds were more potent for α9-containing receptors than for α7, and the majority were either full or strong partial agonists for α9-containing nAChR.
1. A para-substituted 1,1-dialkyl-4-phenylpiperazin-1-ium having the formula:
wherein:
R 1 is a —CO—R 2 group, an oxazole, a pyrazole, or a pyrrole;
R 2 is a pyrrolidine group or an —NH—R 3 group;
R 3 is an alkyl group, an aryl group, a saturated heterocyclic group, a substituted saturated heterocyclic group, an unsaturated heterocyclic group, a substituted unsaturated heterocyclic group, a pyridine, a substituted pyridine group, or a substituted phenyl group; and
R 4 and R 5 are each independently a methyl group or an ethyl group,
or a salt thereof.
2. The para-substituted 1,1-dialkyl-4-phenylpiperazin-1-ium of claim 1 , wherein the compound is selected from the group consisting of the formulae:
or a salt thereof.
3. The para-substituted 1,1-dialkyl-4-phenylpiperazin-1-ium of claim 1 , wherein the salt of the para-substituted 1,1-dialkyl-4-phenylpiperazin-1-ium is an iodide.
4. A method of modulating the electrophysiological activity of a nicotinic acetylcholine receptor (nAChR) of an animal cell, the method comprising contacting an animal cell with a para-substituted 1,1-dialkyl-4-phenylpiperazin-1-ium having the formula:
wherein:
R 1 is a —CO—R 2 group, an oxazole, a pyrazole, or a pyrrole;
R 2 is a pyrrolidine group or an —NH—R 3 group;
R 3 is an alkyl group, an aryl group, a saturated heterocyclic group, a substituted saturated heterocyclic group, an unsaturated heterocyclic group, a substituted unsaturated heterocyclic group, a pyridine, a substituted pyridine group, or a substituted phenyl group; and
R 4 and R 5 are each independently a methyl group or an ethyl group,
or a salt thereof.
5. The method of claim 4 , wherein the compound is selected from the group consisting of the formulae:
or a salt thereof.
6. The method of claim 4 , wherein the salt of the para-substituted 1,1-dialkyl-4-phenylpiperazin-1-ium is an iodide.
7. The method of claim 4 , wherein the nAChR is an α9, an α9α10, or an α7 nAChR.
8. A method of modulating inflammatory signaling by modulating the electrophysiological activity of a nicotinic acetylcholine receptor (nAChR) of an animal cell, the method comprising delivering to an animal cell a para-substituted 1,1-dialkyl-4-phenylpiperazin-1-ium having the formula:
wherein:
R 1 is a —CO—R 2 group, an oxazole, a pyrazole, or a pyrrole;
R 2 is a pyrrolidine group or an —NH—R 3 group;
R 3 is an alkyl group, an aryl group, a saturated heterocyclic group, a substituted saturated heterocyclic group, an unsaturated heterocyclic group, a substituted unsaturated heterocyclic group, a pyridine, a substituted pyridine group, or a substituted phenyl group; and
R 4 and R 5 are each independently a methyl group or an ethyl group,
or a salt thereof.
9. The method of claim 8 , wherein the compound is selected from the group consisting of the formulae:
or a salt thereof.
10. The method of claim 8 , wherein the salt of the para-substituted 1,1-dialkyl-4-phenylpiperazin-1-ium is an iodide.
11. The method of claim 8 , wherein the nAChR is an α9, an α9α10, or an α7 nAChR.